These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19344396)

  • 1. Chronic transfusion practice for children with sickle cell anaemia and stroke.
    Aygun B; McMurray MA; Schultz WH; Kwiatkowski JL; Hilliard L; Alvarez O; Heeney M; Kalinyak K; Lee MT; Miller S; Helms RW; Ware RE;
    Br J Haematol; 2009 May; 145(4):524-8. PubMed ID: 19344396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial.
    Ware RE; Davis BR; Schultz WH; Brown RC; Aygun B; Sarnaik S; Odame I; Fuh B; George A; Owen W; Luchtman-Jones L; Rogers ZR; Hilliard L; Gauger C; Piccone C; Lee MT; Kwiatkowski JL; Jackson S; Miller ST; Roberts C; Heeney MM; Kalfa TA; Nelson S; Imran H; Nottage K; Alvarez O; Rhodes M; Thompson AA; Rothman JA; Helton KJ; Roberts D; Coleman J; Bonner MJ; Kutlar A; Patel N; Wood J; Piller L; Wei P; Luden J; Mortier NA; Stuber SE; Luban NLC; Cohen AR; Pressel S; Adams RJ
    Lancet; 2016 Feb; 387(10019):661-670. PubMed ID: 26670617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease.
    Mirre E; Brousse V; Berteloot L; Lambot-Juhan K; Verlhac S; Boulat C; Dumont MD; Lenoir G; de Montalembert M
    Eur J Haematol; 2010 Mar; 84(3):259-65. PubMed ID: 19912310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: results from the SWiTCH clinical trial.
    Alvarez O; Yovetich NA; Scott JP; Owen W; Miller ST; Schultz W; Lockhart A; Aygun B; Flanagan J; Bonner M; Mueller BU; Ware RE;
    Am J Hematol; 2013 Nov; 88(11):932-8. PubMed ID: 23861242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splenectomy to Optimize Hemoglobin S Control in Children With Sickle Cell Anemia on Chronic Transfusion Therapy for Stroke Prevention.
    Black LV; Ramesar JS; Boston CH
    J Pediatr Hematol Oncol; 2019 Mar; 41(2):158-160. PubMed ID: 29668544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
    Wang WC; Dwan K
    Cochrane Database Syst Rev; 2013 Nov; (11):CD003146. PubMed ID: 24226646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stroke With Transfusions Changing to Hydroxyurea (SWiTCH): a phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overload.
    Ware RE; Schultz WH; Yovetich N; Mortier NA; Alvarez O; Hilliard L; Iyer RV; Miller ST; Rogers ZR; Scott JP; Waclawiw M; Helms RW
    Pediatr Blood Cancer; 2011 Dec; 57(6):1011-7. PubMed ID: 21826782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography.
    Adams RJ; McKie VC; Hsu L; Files B; Vichinsky E; Pegelow C; Abboud M; Gallagher D; Kutlar A; Nichols FT; Bonds DR; Brambilla D
    N Engl J Med; 1998 Jul; 339(1):5-11. PubMed ID: 9647873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High mortality among children with sickle cell anemia and overt stroke who discontinue blood transfusion after transition to an adult program.
    McLaughlin JF; Ballas SK
    Transfusion; 2016 May; 56(5):1014-21. PubMed ID: 26593779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stroke With Transfusions Changing to Hydroxyurea (SWiTCH).
    Ware RE; Helms RW;
    Blood; 2012 Apr; 119(17):3925-32. PubMed ID: 22318199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews.
    Fortin PM; Hopewell S; Estcourt LJ
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012082. PubMed ID: 30067867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of total hemoglobin and hemoglobin S concentration on cerebral blood flow during transfusion therapy to prevent stroke in sickle cell disease.
    Hurlet-Jensen AM; Prohovnik I; Pavlakis SG; Piomelli S
    Stroke; 1994 Aug; 25(8):1688-92. PubMed ID: 8042222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcranial Doppler velocity and brain MRI/MRA changes in children with sickle cell anemia on chronic transfusions to prevent primary stroke.
    Sheehan VA; Hansbury EN; Smeltzer MP; Fortner G; McCarville MB; Aygun B
    Pediatr Blood Cancer; 2013 Sep; 60(9):1499-502. PubMed ID: 23625812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A modified transfusion program for prevention of stroke in sickle cell disease.
    Cohen AR; Martin MB; Silber JH; Kim HC; Ohene-Frempong K; Schwartz E
    Blood; 1992 Apr; 79(7):1657-61. PubMed ID: 1558963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative blood transfusions for sickle cell disease.
    Estcourt LJ; Kimber C; Trivella M; Doree C; Hopewell S
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003149. PubMed ID: 32614473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time to rethink haemoglobin threshold guidelines in sickle cell disease.
    Ballas SK; Kuypers FA; Gordeuk VR; Hankins JS; Thompson AA; Vichinsky E
    Br J Haematol; 2021 Nov; 195(4):518-522. PubMed ID: 34131897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examination of Reticulocytosis among Chronically Transfused Children with Sickle Cell Anemia.
    Kaushal M; Byrnes C; Khademian Z; Duncan N; Luban NL; Miller JL; Fasano RM; Meier ER
    PLoS One; 2016; 11(4):e0153244. PubMed ID: 27116614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusional iron overload in children with sickle cell anemia on chronic transfusion therapy for secondary stroke prevention.
    Kwiatkowski JL; Cohen AR; Garro J; Alvarez O; Nagasubramanian R; Sarnaik S; Thompson A; Woods GM; Schultz W; Mortier N; Lane P; Mueller B; Yovetich N; Ware RE;
    Am J Hematol; 2012 Feb; 87(2):221-3. PubMed ID: 22120913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting changes in hemoglobin S after simple transfusion using complete blood counts.
    Mathur G; Ten Eyck P; Knudson CM
    Transfusion; 2018 Jan; 58(1):138-144. PubMed ID: 29023896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia.
    Miller ST; Wright E; Abboud M; Berman B; Files B; Scher CD; Styles L; Adams RJ;
    J Pediatr; 2001 Dec; 139(6):785-9. PubMed ID: 11743502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.